Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)

Active, not recruitingOBSERVATIONAL
Enrollment

205

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Tuberous SclerosisAutism DisorderIntellectual Disability
Trial Locations (6)

35294

University of Alabama at Birmingham, Birmingham

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

77030

University of Texas at Houston, Houston

90095

University of California at Los Angeles, Los Angeles

94304

Stanford University, Palo Alto

02115

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Tuberous Sclerosis Alliance

OTHER

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

Office of Rare Diseases (ORD)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Boston Children's Hospital

OTHER

NCT02461459 - Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC) | Biotech Hunter | Biotech Hunter